Found: 2
Select item for more details and to access through your institution.
RIG-I acts as a tumor suppressor in melanoma via regulating the activation of the MKK/p38MAPK signaling pathway.
- Published in:
- Human Cell, 2022, v. 35, n. 4, p. 1071, doi. 10.1007/s13577-022-00698-1
- By:
- Publication type:
- Article
USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03730-5
- By:
- Publication type:
- Article